Results 41 to 50 of about 62,455 (259)

Bone marrow edema in sacroiliitis : detection with dual-energy CT

, 2020
Objectives: To evaluate the feasibility and diagnostic accuracy of dual-energy computed tomography (DECT) for the detection of bone marrow edema (BME) in patients suspected for sacroiliitis. Methods: Patients aged 18-55 years with clinical suspicion for
Carron, Philippe, Chen, Min, Elewaut, Dirk, Herregods, Nele, Jans, Lennart, Jaremko, Jacob, Van den Bosch, Filip   +6 more
core   +1 more source

Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors [PDF]

, 2017
The term spondyloarthritis (SpA) is used to describe a group of multifactorial chronic inflammatory diseases characterized by a predisposing genetic background and clinical manifestations typically involving the sacroiliac joint.
Ada Aita, Breban, Daniela Basso, Giovannini, Leonardo Punzi, Maksymowych, Mario Plebani, Massova, Parma, Roberta Ramonda, Stefania Moz, Woo   +11 more
core   +1 more source

Serum concentrations of interleukin-6 and tumor necrosis factor alpha in patients with spondyloarthritis: a relationship between systemic inflammation and anemia

Бюллетень сибирской медицины, 2022
Aim. To assess the relationship between the activity of systemic inflammation and the hemoglobin level in patients with spondyloarthritis (SpA).Materials and methods.
К. N. Safarova, E. A. Fedotov, A. P. Rebrov   +2 more
doaj   +1 more source

Transition From Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype [PDF]

ACR Open Rheumatol
Objective Juvenile dermatomyositis (JDM) is a rare childhood inflammatory myopathy, whereas spondyloarthritis (SpA) is an inflammatory arthropathy characterized by enthesitis and peripheral or axial involvement. We describe a series of patients diagnosed with JDM in childhood who later fulfilled classification criteria for SpA, a sequential phenotype ...
Grooms A, Karageorgiou I, Mychaliska K, Birmingham J.   +3 more
europepmc   +2 more sources

MRI of the axial skeleton in spondyloarthritis : the many faces of new bone formation [PDF]

, 2019
Spondyloarthritis has two hallmark features: active inflammation and structural lesions with new bone formation. MRI is well suited to assess active inflammation, but there is increasing interest in the role of structural lesions at MRI.
Carron, Philippe, Elewaut, Dirk, Herregods, Nele, Jans, Lennart, Jaremko, Jacob L, Laloo, Frederiek, Van den Bosch, Filip, Verstraete, Koenraad   +7 more
core   +1 more source

Immunogenicity, Safety, and Clinical Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Spondyloarthritis (Preliminary Data)

Антибиотики и Химиотерапия, 2022
Background. Immunosuppressive drugs are widely used for the treatment of patients with spondyloarthritis (SpA) to effectively control the activity of the disease.
M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. V. Cherkasova, Zh. G. Verizhnikova, T. V. Korotaeva   +5 more
doaj   +1 more source

The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study [PDF]

, 2017
Background: In this study, we sought to compare the performance of spondyloarthritis (SpA) classification criteria sets in an international SpA cohort with patients included from five continents around the world.
Bakker, Pauline, Dougados, Maxime, Etcheto, Adrien, Landewé, Robert, Moltó, Anna, Van den Bosch, Filip, van der Heijde, Désirée, van Gaalen, Floris   +7 more
core   +2 more sources

Osteoimmunology of Spondyloarthritis

International Journal of Molecular Sciences, 2023
The mechanisms underlying the development of bone damage in the context of spondyloarthritis (SpA) are not completely understood. To date, a considerable amount of evidence indicates that several developmental pathways are crucially involved in osteoimmunology.
Angelo, Fassio, Fabiola, Atzeni, Maurizio, Rossini, Valeria, D'Amico, Francesco, Cantatore, Maria Sole, Chimenti, Chiara, Crotti, Bruno, Frediani, Andrea, Giusti, Giusy, Peluso, Guido, Rovera, Palma, Scolieri, Vincenzo, Raimondo, Davide, Gatti, , On Behalf Of The Study Group On Osteoporosis And Skeletal Metabolic Diseases Of The Italian Society Of Rheumatology   +14 more
openaire   +4 more sources

Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology

Научно-практическая ревматология, 2022
Despite great advances in the diagnosis and treatment of Immune-mediated inflammatory diseases (IMIDs), which have led to a significant improvement in the prognosis in many patients, the central medical problems of this pathology – restoring the quality ...
E. L. Nasonov, T. V. Korotaeva
doaj   +1 more source

Tumor necrosis factor inhibitors in psoriatic arthritis. [PDF]

, 2017
INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can result in significant disability. With the emergence of tumor necrosis factor inhibitors (TNFi), therapeutic outcomes in PsA have improved substantially.
Kraft, Walter K., Mantravadi, Santhi, Ogdie, Alexis   +2 more
core   +2 more sources